|
|
2009-05-04 - Financial Times ArticleBiotronics3D puts investment to good use Recently Biotronics3D featured in a Financial Times article about the impact the current economic and manufacturing difficulties were having in relation to financial backing of companies. Innovative companies like us who would have normally gone to banks for loans are now turning for financial assistance to business angels or venture capitalists. The investment has enabled us to grow as a company and as a result we are working towards expanding our product range and software suites, services and solutions for specific diseases such as prostate cancer and oncology generally. At a time when most of our competitors have either chosen, or been forced, to discard their research and development investment, we have been resourced to expand ours. While this is good for Biotronics3D, it is also excellent news for patients, doctors and hospital staffs. It also means that our capital investors have a very positive outlook for a return on their investment in spite of general economic uncertainty. |
 |